Capablanca, Rose A.
HRN: 26-37-54 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2025
AMPICILLIN 250MG (VIAL)
02/03/2025
02/10/2025
IV
200mg
Q6h
Pneumonia
Waiting Final Action
02/03/2025
CEFOTAXIME 500MG (VIAL)
02/03/2025
02/10/2025
IV
150mg
Q6hours
PCAP-C
Waiting Final Action
02/10/2025
CEFTRIAXONE 1G (VIAL)
02/10/2025
02/16/2025
IV
200mg
Q12
PCAP-C
Waiting Final Action